Uwe Mellinger

2.1k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Uwe Mellinger is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Uwe Mellinger has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 20 papers in Reproductive Medicine and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Uwe Mellinger's work include Reproductive Health and Contraception (23 papers), Hormonal and reproductive studies (12 papers) and Ovarian function and disorders (10 papers). Uwe Mellinger is often cited by papers focused on Reproductive Health and Contraception (23 papers), Hormonal and reproductive studies (12 papers) and Ovarian function and disorders (10 papers). Uwe Mellinger collaborates with scholars based in Germany, United States and Australia. Uwe Mellinger's co-authors include Susanne Parke, Marco Serrani, C. Moore, Inka Wiegratz, Jeffrey T. Jensen, H. Kühl, Ulrich Winkler, Ian S. Fraser, E Kutschera and A. Machlitt and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Human Reproduction.

In The Last Decade

Uwe Mellinger

47 papers receiving 1.4k citations

Hit Papers

Elinzanetant for the Treatment of Vasomotor Symptoms Asso... 2024 2026 2025 2024 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
    2024 39 citations Uwe Mellinger, Susanne Parke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Mellinger Germany 22 776 691 531 295 169 48 1.5k
Neil F. Goodman United Kingdom 12 430 0.6× 655 0.9× 535 1.0× 88 0.3× 196 1.2× 20 1.3k
Susanne Tan Germany 27 905 1.2× 1.6k 2.3× 503 0.9× 100 0.3× 87 0.5× 62 2.4k
Ken Muse United States 21 500 0.6× 588 0.9× 145 0.3× 334 1.1× 110 0.7× 36 1.5k
Rosario Reyna United States 8 1.3k 1.6× 2.0k 3.0× 538 1.0× 137 0.5× 102 0.6× 8 2.4k
Maria Concetta Musacchio Italy 15 433 0.6× 638 0.9× 234 0.4× 132 0.4× 57 0.3× 25 974
Л. В. Сутурина Russia 15 756 1.0× 1.2k 1.7× 234 0.4× 116 0.4× 97 0.6× 77 1.5k
Oscar Levalle Argentina 20 287 0.4× 472 0.7× 805 1.5× 231 0.8× 113 0.7× 43 1.5k
Daniela Romualdi Italy 25 647 0.8× 1.0k 1.5× 319 0.6× 117 0.4× 63 0.4× 53 1.4k
Duru Shah India 13 423 0.5× 524 0.8× 378 0.7× 66 0.2× 182 1.1× 41 1.2k
A Czyźyk Poland 17 467 0.6× 669 1.0× 256 0.5× 121 0.4× 146 0.9× 76 1.3k

Countries citing papers authored by Uwe Mellinger

Since Specialization
Citations

This map shows the geographic impact of Uwe Mellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Mellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Mellinger more than expected).

Fields of papers citing papers by Uwe Mellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Mellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Mellinger. The network helps show where Uwe Mellinger may publish in the future.

Co-authorship network of co-authors of Uwe Mellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Mellinger. A scholar is included among the top collaborators of Uwe Mellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Mellinger. Uwe Mellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerlinger, Christoph, James Trussell, Uwe Mellinger, et al.. (2014). Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population. Contraception. 90(2). 142–146. 14 indexed citations
2.
Wiegratz, Inka, Susana Bassol, Edith Weisberg, Uwe Mellinger, & Martin Merz. (2014). Effect of a Low-Dose Contraceptive Patch on Efficacy, Bleeding Pattern, and Safety: A 1-Year, Multicenter, Open-Label, Uncontrolled Study. Reproductive Sciences. 21(12). 1518–1525. 8 indexed citations
3.
Petraglia, Felice, Susanne Parke, Marco Serrani, Uwe Mellinger, & Thomas Römer. (2014). Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea. International Journal of Gynecology & Obstetrics. 125(3). 270–274. 14 indexed citations
4.
Davis, Susan R., Johannes Bitzer, Annamaria Giraldi, et al.. (2013). Change to Either a Nonandrogenic or Androgenic Progestin-Containing Oral Contraceptive Preparation is Associated with Improved Sexual Function in Women with Oral Contraceptive-Associated Sexual Dysfunction. The Journal of Sexual Medicine. 10(12). 3069–3079. 63 indexed citations
5.
Schumacher, Ulrike, Jens Schumacher, Uwe Mellinger, et al.. (2012). Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Women s Health. 12(1). 24–24. 19 indexed citations
6.
Fraser, Ian S., Thomas Römer, Susanne Parke, et al.. (2011). Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Human Reproduction. 26(10). 2698–2708. 65 indexed citations
7.
Klipping, Christine, Ingrid Duijkers, Susanne Parke, et al.. (2011). Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive. Drugs in R&D. 11(2). 159–170. 60 indexed citations
8.
Klipping, Christine, Ingrid Duijkers, Susanne Parke, et al.. (2011). Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive. Drugs in R&D. 11(2). 159–170. 3 indexed citations
9.
Wiegratz, Inka, Nicole Sänger, Katrin Mittmann, et al.. (2010). Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use. Hormone and Metabolic Research. 42(5). 358–363. 11 indexed citations
10.
Wiegratz, Inka, Nicole Sänger, Katrin Mittmann, et al.. (2009). Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use. Contraception. 81(1). 57–61. 20 indexed citations
11.
Minnemann, T, Markus Schubert, S Freude, et al.. (2008). Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism. Journal of Endocrinological Investigation. 31(8). 718–723. 30 indexed citations
12.
13.
14.
15.
Mellinger, Uwe, et al.. (2005). In vitro- und klinische Untersuchungen zum Unterschied von apothekengefertigten Testosteron-haltigen transdermalen Anwendungsformen und dem Produkt Testogel (R). Journal für Kardiologie (Krause & Pachernegg GmbH). 3(2). 20–24. 1 indexed citations
16.
Palombo‐Kinne, Ernesta, et al.. (2004). Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression. Climacteric. 7(3). 301–311. 29 indexed citations
17.
Wiegratz, Inka, E Kutschera, C. Moore, et al.. (2003). Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception. 67(1). 25–32. 189 indexed citations
18.
Wiegratz, Inka, E Kutschera, C. Moore, et al.. (2003). Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters. Contraception. 67(5). 361–366. 56 indexed citations
19.
Hippius, Marion, et al.. (1998). Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?. European Journal of Clinical Pharmacology. 54(9-10). 729–734. 24 indexed citations
20.
Spona, J., Wilfried Feichtinger, C. Moore, et al.. (1997). Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest. Contraception. 56(3). 185–191. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil F. Goodman Breakdown of academic impact, for papers by Susanne Tan Breakdown of academic impact, for papers by Ken Muse Breakdown of academic impact, for papers by Rosario Reyna Breakdown of academic impact, for papers by Maria Concetta Musacchio Breakdown of academic impact, for papers by Л. В. Сутурина Breakdown of academic impact, for papers by Oscar Levalle Breakdown of academic impact, for papers by Daniela Romualdi Breakdown of academic impact, for papers by Duru Shah Breakdown of academic impact, for papers by A Czyźyk
Rankless by CCL
2026